CME INFORMATION PAGE
Content Links:
Program Overview - Year one:
Mirroring the academic grand rounds programs, these CME programs combine traditional academic grand rounds with the innovation and convenience of telemedicine. This weekly webinar program, broadcast from the Perelman School of Medicine at the University of Pennsylvania, and delivered by top experts in the field, covers a wide range of topics involved with the clinical care of patients with HIV/AIDS.
The one-hour presentations will be designed to be immediately relevant to practicing HIV clinicians and many will be case-based. The final 10 minutes of each one-hour program will consist of a live question and answer period with the presenting faculty member available to answer questions asked by participants who attend in person or via the Internet. These weekly grand rounds programs are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.
Series Overview - Years two & three:
The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to announce the extension of this ground-breaking CME activity. Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The "HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania" is delivered live via the Internet weekly and archived for on-demand viewing twenty-four hours after each live broadcast.
Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based. The final 10 minutes of each one-hour activity consists of a question and answer period. These weekly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.
Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/grandrounds for easy access.
Target Audience - Year One:
This activity has been designed to meet the educational needs of physicians, other health care providers, and pharmacists who diagnose and manage patients with HIV/AIDS.
Target Audience - Year Two:
This educational activity is designed for HIV specialists, Infectious Disease specialists, Internal Medicine specialists, Family Practice physicians, Dermatologists, Osteo-specialists, Nephrologists, Hematology/oncologist, Psychiatrists, Public Health professionals, OB/GYN physicians and other clinicians interested and involved in the care of patients with HIV/AIDS.
Target Audience - year Three:
The program has been designed for physicians, fellows, residents, medical students, nurses, nurse practitioners, physician assistants and allied health professionals in the medical specialties of Dermatology, Nephrology, Hematology/Oncology and Psychiatry as well as OB/GYN physicians, Osteo-specialists, Infectious Disease specialists, Public Health professionals and other clinicians interested and involved in the care of patients with HIV/AIDS.
Commercial Support Acknowledgement - Years One through Three: HIV Grand Rounds is supported by educational grants from Gilead Sciences Medical Affairs and Janssen Therapeutics, Division of Janssen Products, LP
Learning Objectives - Year one:
Upon completion of the program, participants should be able to:
-
List the important factors that play a role in ARV therapy success;
-
Explain the role that drug adverse events, drug pharmacokinetics and patient adherence play in achieving ARV success and avoiding morbidity and mortality;
-
Describe the important opportunistic infections and co-morbidities that may affect HIV-positive patients and increase their risk for morbidity and mortality;
-
Discuss the importance of individualizing the care of each HIV-positive patient.
Learning Objectives - Years Two & Three:
Upon completion of the educational activity, participants should be able to:
-
Improve knowledge and ability to use ARV therapy successfully;
-
Improve the knowledge of how drug adverse events, drug pharmacokinetics and patient adherence can affect ARV success and through the application of this knowledge avoid morbidity and mortality;
-
Improve knowledge of opportunistic infections and co-morbidities that may affect HIV-positive patients and increase their risk for morbidity and mortality;
-
Improve understanding of the importance of individualizing the care of each HIV-positive patient.
Back to Top
Course Directors - years One through Three:
 |
John G. Bartlett, MD
Chief, Division of Infectious Diseases
Stanhope Bayne Jones Professor of Medicine
Director, HIV Care Program
Johns Hopkins School of Medicine
Baltimore, Maryland
|
 |
Calvin J. Cohen, MD MS
Research Director
CRI New England
Clinical Instructor
Harvard Medical School
Boston, Massachusetts
|
 |
Ian Frank, MD
Professor of Medicine,
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
|
|
Faculty - Year One:
|
Frederick Altice, MD
Professor of Medicine
Director of Clinical Research and Community Research
Yale University School of Medicine
Section of Infectious Diseases, AIDS Program
New Haven, Connecticut
|
|
Gregory Melikian, PhD
Professor, Department of Pediatrics
Division of Infectious Diseases
Emory University
Atlanta, Georgia
|
 |
Gregory Bisson, MD
Assistant Professor of Medicine
Infectious Diseases Division
University of Pennsylvania School of Medicine
Assistant Professor of Epidemiology
Center for Clinical Epidemiology & Biostatistics
Philadelphia, Pennsylvania
|
 |
David S. Metzger, PhD
Research Professor of Social Policy in Psychiatry
Director, HIV Prevention Research Division
University of Pennsylvania
Department of Psychiatry
Philadelphia, Pennsylvania
|
 |
Jason Brenchley, PhD
Investigator, Molecular Microbiology
Viral Pathogenesis and Vaccine
National Institute for Allergies and Infectious Diseases
Bethesda, Maryland
|
 |
Karam Mounzer, MD
Medical Director
The Jonathan LAX Center
Philadelphia FIGHT
Philadelphia, Pennsylvania
|
Back to Top |
|
|
|
 |
Todd T. Brown, MD PhD
Assistant Professor of Medicine
Division of Endocrinology and Metabolism
Johns Hopkins University
Baltimore, Maryland
|
 |
K. Rajender Reddy, MD
Professor of Medicine
Professor of Medicine in Surgery
Director of Hepatology
Director of Viral Hepatitis Center
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Richard A. Elion, MD
Associate Professor of Clinical Medicine
George Washington University Medical Center
Research Director
Director Whitman-Walker Clinic
Washington, DC
|
|
Deirdre Sawinski, MD
Assistant Professor of Medicine
Renal, Electrolyte and Hypertension Division
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Joseph Eron, MD
Professor
University of North Carolina
School of Medicine
Chapel Hill, North Carolina
|
 |
David M. Simpson MD
Professor of Neurology
Director, Clinical Neurophysiology Laboratories
Director, Neuro-AIDS Program
Mount Sinai Medical Center
New York, New York
|
Back to Top |
|
|
|
 |
Joseph Garland, MD
Fellow
Division of Infectious Diseases
Department of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Mark Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland
|
 |
Kelly Gebo, MD MPH
Associate Professor of Medicine, Epidemiology
Johns Hopkins University
School of Medicine
Baltimore, Maryand
|
 |
Pablo Tebas, MD
Director, AIDS Clinical Trials Unit
University of Pennsylvania
School of Medicine
Philadelphia, Pennsylvania
|
 |
Robert Gross, MD
Associate Professor of Medicine (Infectious Diseases)
Associate Professor of Epidemiology
Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
|
 |
Glenn J. Treisman, MD
Professor of Psychiatry and Behavioral Sciences
Professor of Internal Medicine
Director of the AIDS Psychiatry Program
Johns Hopkins University School of Medicine
Baltimore, Maryland
|
Back to Top |
|
|
|
 |
Trevor Hawkins, MD
Associate Professor
University of New Mexico
Medical Director
Southwest CARE Center
Santa Fe, New Mexico
|
 |
Christopher Vinnard, MD
Fellow, Infectious Diseases
University of Pennsylvania
School of Medicine
Philadelphia, Pennsylvania
|
 |
Jay Kostman, MD
Clinical Associate Professor of Medicine
Division of Infectious Diseases
Chief, Infectious Diseases Division
Penn Presbyterian Medical Center
University of Pennsylvania
Philadelphia, Pennsylvania
|
|
Amy Vittor, MD PhD
Fellow, Infectious Diseases
University of Pennsylvania
School of Medicine
Philadelphia, Pennsylvania
|
 |
Carrie Kovarik, MD
Assistant Professor
Departments of Dermatology and Infectious Diseases
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
|
 |
Baligh Yehia, MD
Fellow, Infectious Diseases
University of Pennsylvania
School of Medicine
Philadelphia, Pennsylvania
|
Back to Top |
|
|
|
 |
Andrew Zolopa, MD
Associate Professor of Medicine
Division of Infectious Diseases
Stanford University School of Medicine
Stanford, California
|
|
|
Faculty - Years Two & Three:
 |
Jay Kostman, MD
Clinical Associate Professor of Medicine
Division of Infectious Diseases
Chief, Infectious Diseases Division
Penn Presbyterian Medical Center
University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
K. Rajender Reddy, MD
Professor of Medicine
Professor of Medicine in Surgery
Director of Hepatology
Director of Viral Hepatitis Center
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Vincent Lo Re III, MD
Clinical Associate Professor of Medicine,
Division of Infectious Diseases
Penn Presbyterian Medical Center
University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Robert Siliciano, MD PhD
Professor of Medicine,
Molecular Biology and Genetics
Howard Hughes Medical Institute
Johns Hopkins University School of Medicine
Baltimore, Maryland
|
 |
Priscilla Hsue, MD
Associate Professor of Medicine
Division of Cardiology
University of California, San Francisco
School of Medicine
San Francisco, California
|
 |
Louis J. Picker, MD
Associate Director
Vaccine and Gene Therapy Institute
Head, Pathobiology and Immunology Division
Oregon Health and Science University
Portland, Oregon
|
Back to Top |
|
|
|
 |
Timothy Wilkin, MD MPH
Associate Professor of Medicine
Division of Infectious Diseases
Weill Medical College of Cornell University
New York, New York
|
 |
David Wohl, MD
Associate Professor of Medicine
Division of Infectious Diseases, School of Medicine
The University of North Carolina, Chapel Hill, North Carolina
Co-Director of HIV Services for the North Carolina
Department of Corrections
Chapel Hill, North Carolina
|
 |
Steven G. Deeks, MD
Professor of Medicine
University of California, San Francisco
San Francisco, California
|
 |
Pablo Tebas, MD
Director, AIDS Clinical Trials Unit
University of Pennsylvania
School of Medicine
Philadelphia, Pennsylvania
|
 |
Todd Barton, MD
Associate Professor of Medicine
The Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Ian M. McGowan, MD PhD
Professor of Medicine
Division of Gastroenterology, Hepatology and Nutrition
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
|
Back to Top |
|
|
|
 |
Chloe L. Thio, MD
Professor of Medicine
Division of Infectious Diseases
John Hopkins University
Baltimore, Maryland
|
 |
Renslow D. Sherer, MD
Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois
|
 |
Charles B. Hicks, MD
Professor of Medicine
Department of Infectious Diseases
Duke University Medical Center
Durham, North Carolina
|
 |
Beatrice H. Hahn, MD
Professor of Medicine and Microbiology
University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Robert M. Grant, MD MPH
Betty Jean and Hiro Ogawa Endowed Investigator
Gladstone Institute of Virology and Immunology
Associate Professor of Medicine
University of California, San Francisco
San Francisco, California
|
 |
George M. Shaw, MD PhD
Professor of Medicine
Division of Hematology / Oncology
University of Pennsylvania
Philadelphia, Pennsylvania
|
Back to Top |
|
|
|
 |
Robert Gross, MD
Associate Professor of Medicine (Infectious Diseases)
Associate Professor of Epidemiology
Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
|
 |
Doreen Ramogola-Masire, MD
Country Director and Lead Physician Women's Health
Botswana UPenn Partnership
Gaborone, Botswana
|
 |
James D. Neaton, PhD
Professor of Biostatistic
University of Minnesota School of Public Health
Minneapolis, Minnesota
|
 |
Una O'Doherty, MD PhD
Associate Professor of Pathology
and Laboratory Medicine
The Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Michel C. Nussenzweig, PhD
Sherman Fairchild Professor
Rockefeller University
Investigator, HHMI laboratory of Molecular Immunology
New York, New York
|
 |
Valerianna Amorosa, MD
Chief of Infectious Diseases, VAMC Assistant Professor
of Clinical Medicine
The Perelman SOM at the University of Pennsylvania
Philadelphia, Pennsylvania
|
Back to Top |
|
|
|
 |
Michael R. Betts, PhD
Assistant Professor
Department of Microbiology
Perelman School of Medicine
University of Pennsylvania
|
 |
Chris Beyrer, MD MPH
Professor
Director, Johns Hopkins Fogarty AIDS International
Training and Research Program
Director, Johns Hopkins Center for Public health
and Human Rights
Senior Scientific Liaison, HIV Vaccine Trials Network
Associate Director of Public Health, Johns Hopkins Center for
Public Health
Baltimore, Maryland
|
 |
Daniel R. Kuritzkes, MD
Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine, Harvard Medical School
Boston, Massachusetts
|
 |
Thomas Coyne, MD PhD
Department of Pathology
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
|
|
Jeffrey Hafkin, MD
Fellow, Infectious Diseases
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Amy A. Pruitt, MD
Associate Professor of Neurology
Hospital at the University of Pennsylvania
Philadelphia, Pennsylvania
|
Back to Top |
|
|
|
 |
Ronald L. Wolf, MD PhD
Associate Professor of Radiology
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Corey Casper, MD MPH
Associate Member, Vaccine and Infectious Disease, Public Health Science and Clinical Research Divisions
Fred Hutchinson Cancer Research Center
Associate Professor of Medicine, Epidemiology and Global Health University of Washington
Medical Director of Infection Control, Seattle Cancer Care Alliance
Seattle, Washington
|
 |
Marshall J. Glesby, MD PhD
Associate Professor of Medicine and
Associate Professor of Public Health
Weill Cornell Medical College
Associate attending Physician
New York-Presbyterian Hospital
New York, New York
|
 |
David M. Margolis, MD
Professor of Medicine, Microbiology and Immunology,
Epidemiology
Director, Program in Translational Clinical Research
IGHID
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
|
 |
Peter W. Hunt, MD
Assistant Professor in Residence
University of California, San Francisco
San Francisco, California
|
 |
Domenico Mavilio, MD PhD
Group Leader
Clinical and Experimental Immunology
Instituto Clinico Humanitas
Rozzano, Milano Italy
|
Back to Top |
|
|
|
 |
Luis J. Montaner, DVM DPhil
Wistar Institute Professor of Medicine
Director, HIV-1 Immunopathogenesis Laboratory
The Wistar Institute
Philadelphia, Pennsylvania
|
 |
Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts
|
 |
Roy M. Gulick, MD
Chief of the Division of Infectious Diseases
Professor of Medicine
Weill Medical College
Cornell University
New York, New York
|
 |
Lawrence Corey, MD
President and Director
Fred Hutchinson Cancer Research Center
Professor, Medicine and Laboratory Medicine
University of Washington
Seattle, Washington
|
 |
Vincent Lo Re III, MD
Clinical Associate Professor of Medicine,
Division of Infectious Diseases
Penn Presbyterian Medical Center
University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Jay Kostman, MD
Clinical Associate Professor of Medicine
Division of Infectious Diseases
Chief, Infectious Diseases Division,
Penn Presbyterian Medical Center
University of Pennsylvania
Philadelphia, Pennsylvania
|
Back to Top |
|
|
|
Faculty - Years Two & Three (continued):
 |
Mark Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland
|
 |
Myron S. Cohen, MD
J. Herbert Bate Professor
Medicine, Microbiology and Immunology and Epidemiology
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
|
 |
Helen C. Koenig, MD MPH
Clinical Assistant Professor
Hospital at the University of Pennsylvania
Physician, LAX Center
Philadelphia, Pennsylvania
|
 |
Baligh R. Yehia, MD MSHP
Department of Medicine
University of Pennsylvania
Perelman School of Medicine
Philadelphia, Pennsylvania
|
 |
Daniel E. Everitt, MD
Senior Medical Officer
TB Alliance
New York, New York
|
 |
Martin Markowitz, MD
Clinical Director and Staff Investigator
Aaron Diamond AIDS Research Center
Aaron Diamond Professor at the Rockefeller University
New York, New York
|
Back to Top |
|
|
|
 |
Ned C. Sacktor, MD
Professor of Neurology
Johns Hopkins University School of Medicine
Joint Appointment, Department of International Health
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland
|
 |
Jennifer Cohn, MD MPH
Assistant Professor and Director of the Global Health Equities Residency
University of Pennsylvania
Policy Advisor for East Africa for Medecins Sans Frontieres Access Campaign
Philadelphia, Pennsylvania
|
 |
Robin J. Shattock PhD
Chair in Mucosal Infection and Immunity, Division of Infectious Diseases
Department of Medicine
Imperial College London
London, England
|
 |
John W. Ward, MD
Director, Division of Viral Hepatitis
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
Centers for Disease Control and Prevention
Atlanta, Georgia
|
 |
Kenneth Hugh Mayer MD
Medical Research Director, Fenway Health
Attending Physician, Beth Israel Deaconess Medical Center
Visiting Professor, Harvard School of Public Health
Boston, Massachusetts
|
 |
Elmi Muller, MD
Transplant Surgeon
Groote Schuur Hospital
Cape Town, South Africa
|
Back to Top |
|
|
|
 |
Karam Mounzer, MD
Medical Director
The Jonathan LAX Center
Philadelphia FIGHT
Philadelphia, Pennsylvania
|
 |
Andrew J. Muir, MD MHS
Associate Professor of Medicine
Division of Gastroenterology
Director, Gastroenterology / Hepatology Research
Duke Clinical Research Institute
Duke University School of Medicine
Durham, North Carolina
|
 |
Thomas J. Hope, PhD
Professor
Department of Cell and Molecular Biology
Northwestern University Feinberg School of Medicine
Chicago, Illinois
|
 |
Mohamed Atta, MD MPH
Associate Professor of Medicine Renal Division
Johns Hopkins School of Medicine
Baltimore, Maryland
|
|
David Holtzman, MD
Infectious Disease
University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Marion G. Peters, MD
Professor of Medicine
John V. Carbone MD Endowed Chair of Medicine
Chief of Hepatology Research
University of California
San Francisco, California
|
Back to Top |
|
|
|
 |
Kenneth E. Sherman, MD PhD
Gould Professor of Clinical Medicine
Director, Division of Digestive Diseases
University of Cincinnati
Cincinnati, Ohio
|
 |
Benoit Dubé, MD
Assistant Professor of Clinical Psychiatry
Associate Director for Medical Student Education in Psychiatry
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
David W. Haas, MD
Professor of Medicine
Professor of Pharmacology
Professor of Pathology, Microbiology and Imunology
Vanderbilt University School of Medicine
Nashville, Tennessee
|
 |
Richard E. Chaisson, MD
Professor of Medicine
Director, Center for Tuberculosis research
Director, Center for AIDS Research
Johns Hopkins University School of Medicine
Professor of Epidemiology and International Health
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland
|
 |
Marcus Altfeld, MD PhD
Professor of Medicine, Harvard Medical School
The Ragon Institute of MGH, MIT and Hartford
Boston, Massachusetts
|
 |
Hashem B. El-Serag, MD MPH
Dan L. Duncan Professor of Medicine
Chief, Gastroenterology and Hepatology Section
Baylor College of Medicine
Houston, Texas
|
Back to Top |
|
|
|
 |
Susan Cu-Uvin, MD
Professor, Obstetrics and Gynecology and Medicine
Professor, Health Services, Policy and Practice
Director, Global Health Initiative
Brown University
The Miriam Hospital
Providence, Rhode Island
|
 |
Peter S. Gilbert, PhD
Member, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center
Principal Investigator, Statistical Center for the HIV Vaccine Trials Network
Research Professor, Department of Biostatistics
University of Washington
Seattle, Washington
|
 |
Calvin J. Cohen, MD MS
Research Director
CRI New England
Clinical Instructor
Harvard Medical School
Boston, Massachusetts
|
 |
Ian Frank, MD
Professor of Medicine,
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Nezam H. Afdhal, MD
Professor of MedicineHarvard Medical School
Chief of Hepatology, Director of Liver Center
Beth Israel Deaconess Medical Center
Boston, Massachusetts
|
 |
David R. Holtgrave, PhD
Professor and Department Chair
Department of Health, Behavior and Society
Johns Hopkins Bloomberg School of Medicine
Baltimore, Maryland
|
Back to Top |
|
|
|
 |
John G. Bartlett, MD
Chief, Division of Infectious Diseases
Stanhope Bayne Jones Professor of Medicine
Director, HIV Care Program
Johns Hopkins School of Medicine
Baltimore, Maryland
|
 |
Alain H. Litwin, MD MPH
Associate Professor of Clinical Medicine
Associate Professor of Clinical Psychiatry & Behavioral Sciences
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, New York
|
 |
Mark A. Wainberg, MD
Professor of Medicine and Microbiology & Immunology
McGill University
Director, McGill University AIDS Center
Montreal, Quebec
|
 |
Ian Frank, MD
Professor of Medicine,
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Andrew R. Zolopa, MD
Professor
Stanford University School of Medicine
Director, Positive Care Clinic
Palo Alto, California
|
 |
David E. Kaplan, MD MSc
Assistant Professor of Medicine at the Veteran's Administration Medical Center
Attending Gastroenterologist / Hepatologist
Philadelphia VA Medical Center
Philadelphia, Pennsylvania
|
Back to Top |
|
|
|
 |
Pablo Tebas, MD
Professor of Medicine
Hospital of the University of Pennsylvania
Director, Adult AIDS Clinical Trials Unit (ACTU)
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Judith D. Auerbach, PhD
Independent Science & Policy Consultant
Adjunct Professor
School of Medicine, University of California
San Francisco, California
|
 |
Elizabeth Lowenthal, MD MSCE FAAP AAHIVS
Faculty, Division of General Academic Pediatrics
Center for Pediatric Clinical Effectiveness, and Global Health
Children's Hospital of Philadelphia
Assistant Professor of Pediatrics and Epidemiology
Perelman School of Medicines at the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Gregory T. Everson, MD FACP
Professor of Medicine
Director, Section of Hepatology
University of Colorado
Aurora, Colorado
|
 |
Ian Frank, MD
Professor of Medicine
Director, Clinical-Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Pablo Tebas, MD
Professor of Medicine
Hospital of the University of Pennsylvania
Director, Adult AIDS Clinical Trials Unit (ACTU)
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
Back to Top |
|
|
|
 |
Robert Gross, MD MSCE
Associate Professor of Medicine
Infectious Diseases Division
Associate Professor of Epidemiology
Department of Biostatistics & Epidemiology
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Baligh R. Yehia, MD
Fellow, Infectious Diseases
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Mark Harrington
Executive Director
Treatment Action Group (TAG)
New York, New York
|
 |
Jessica S. Merlin, MD MBA
Assistant Professor of Medicine
Divisions of Infectious Diseases and Gerontology, Geriatrics, and Palliative Care
University of Alabama Birmingham
Birmingham, Alabama
|
 |
Calvin J. Cohen, MD, MS
Research Director
CRI New England
Clinical Instructor
Harvard Medical School
Boston, Massachusetts
|
 |
Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
Back to Top |
|
|
|
 |
K. Rajender Reddy, MD
Professor of Medicine
Professor of Medicine in Surgery
Director of Hepatology
Director of Viral Hepatitis Center
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
|
|
|
|
|
|
|
|
|
|
Frequently Asked Questions (FAQs) - Year one only:
-
Above, on the right hand side, is a tab labeled "FAQS".
-
Viewer questions and faculty responses regarding the enduring programs will be posted here for participant review.
-
You may sort through these by selecting the week you are interested in viewing.
Discussion Forum - year one only:
-
Above, on the right hand side, is a tab labeled "View/Join Discussion".
-
Participants may initiate, join, or read discussion forums in this location.
Hardware/Software Notice:
You will need Internet to participate in this activity.
Accreditation Statement - Years two & Three:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc.. The Perelman School of Medicine at the University of Pennsylvania is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement - Years Two & Three:
The Perelman School of Medicine at the University of Pennsylvania designates each enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflict of Interest - Years two & Three:
It is policy at the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc. for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania (Rodman Campbell, Mila Kostic, Belinda Rose, and Mindy Pollock Troy), our educational partner ViralEd, Inc. (Richard Gordon, Brian Boyle, MD, JD and Ed Hettman), and the peer reviewer, Zalman Agus, MD, Associate Dean for Continuing Medical Education, have reported that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.
Back to Top
The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
John Bartlett, MD
|
Susan Cu-Uvin, MD
|
Robert Siliciano, MD
|
Todd Barton, MD
|
Chloe L. Thio, MD
|
Beatrice H. Hahn MD
|
Peter S. Gilbert, PhD
|
Myrone S. Cohen MD |
Geroge M. Shaw, MD PhD
|
Doreen Ramogola-Masire, MD
|
James D. Neaton, PhD
|
Ian McGowan, MD
|
Michel C. Nussenzweig, MD PhD
|
Valeriana Amorosa, MD
|
Michael Betts PhD
|
Una O'Doherty MD PhD
|
Chris Beyrer MD MPH
|
Reuben S. Harris PhD
|
Jeffrey Hafkin MD |
Thomas Coyne MD PhD |
Amy Pruitt MD |
Ronald L. Wolf MD PhD |
Corey Casper MD MPH |
Domenico Mavilio MD PhD |
Helen C. Koenig MD |
Baligh R. Yehia MD MSHP
|
Ned C. Sacktor MD
|
Jennifer Cohn, MD |
Robin J. Shattock PhD |
John W. Ward MD |
Elmi Muller MD |
Thomas J. Hope PhD |
David Holtzman MD |
Benoit Dubé MD |
Hashem B. El-Serag, MD MPH |
Brandon F. Keele PhD |
David R. Holtgrave, PhD |
John G. Bartlett, MD |
David E. Kaplan, MD MSc |
Baligh R. Yehia, MD |
Jessica S. Merlin, MD MBA |
|
|
|
The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:
Calvin J. Cohen, MD |
Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec; ViiV
|
Contracted Research
|
|
Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec; Abbott
|
Consulting Fees
|
|
Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec
|
Speakers Bureaus
|
Vincent Lo Re III, MD
|
AstraZeneca, Bristol-Myers Squibb
|
Contracted Research
|
K. Rajender Reddy, MD
|
Merck, Genentech-Roche, Vertex, Gilead, Janssen, BMS
|
Advisory Board
|
Back to Top |
Merck, BMS, Gilead, Vertex, Janssen, Abbot
|
Clinical Research - Support to the Institution
|
Priscilla Hsue, MD
|
Bristol-Myers Squibb
|
Speakers Bureau
|
Louis Picker, MD
|
CMV Vector Technology
|
Contracted Research
|
Timothy Wilkin, MD
|
GlaxoSmithKline
|
Contracted Research
|
David Wohl, MD
|
Merck, GlaxoSmithKline
|
Contracted Research
|
Back to Top |
Merck, BMS, Gilead, Bristol-Myers Squibb; Abbott; Tibotec
|
Consulting Fees
|
Steven Deeks, MD
|
Merck, Gilead Sciences
|
Contracted Research
|
|
Tobira; ViiV
|
Consulting Fees
|
Pablo Tebas, MD
|
GlaxoSmithKline
|
Adjudication Committee
|
|
Cytheris
|
DSMB Committee
|
|
GlaxoSmithKline; BMS; Gilead; Pfizer; Vertex; Inovio
|
Contracted Research
|
Renslow Sherer, MD
|
BMS: Abbott
|
Grant Support for Research
|
Back to Top |
Gilead; Abbott
|
Advisory Board with Honoraria
|
Charles Hicks MD
|
Argos
|
Grand Support -PI
|
|
BMS; Gilead; Merck; Tibotec / Janssen; GSK/ViiV
|
Grant Support / Honorarium - PI / Advisory Board
|
Robert M. Grant MD MPH
|
Gilead - Donation of study drug for NIH funded research
|
Investigator
|
Robert Gross, MD MSCE
|
BMS
|
Research Investigator
|
Daniel R. Kuritzkes, MD
|
Abbott, BSC, Boehringer-Ingelheim, Gilead, Merck, Roche & ViiV
|
Consultant
|
Back to Top |
Gilead & Merck
|
Principal Investigator
|
|
Roche |
Speaker |
Marshall J. Glesby, MD, PhD
|
Pfizer; SIGA Technologies
|
Consultant
|
|
Pfizer
|
Clinical Trial Researcher
|
David M. Margolis, MD
|
Merck, BMS, Gilead, GSK
|
Research & Materials Funding
|
|
Gilead
|
Common Stock
|
|
Merck, BMS, GSK, Chimerix, Boehringer, ViiV |
Consulting Honoraria |
Back to Top |
Argos, Tibotec |
Clinical Trial Funding |
Peter W. Hunt, MD
|
Merck
|
Consultant
|
|
Pfizer, Salix, Roche
|
Investigator-Initiated Study
|
|
Boehringer-Ingelheim, Gilead |
Speaker |
Luis J. Montaner, DVM DPhil
|
Pfizer
|
Research Investigator
|
Paul E. Sax, MD
|
Abbott, Aileron, BMS, Gilead, GSK, Merck, Tibotec
|
Consultant
|
Back to Top |
BMS, Gilead, Merck, GSK, Tibotec
|
Hospital Grant
|
Roy M. Gulick, MD, MPH
|
BMS, Gilead, Janssen
|
Ad-hoc Consultant (honorarium)
|
Lawrence Corey, MD
|
Immune Design Corp
|
Stock holder; Scientific Advisory Board
|
Vincent Lo Re III, MD
|
AstraZeneca, Bristol-Myers Squibb
|
Contracted Research
|
Jay Kostman, MD
|
Vertex; Merck
|
Consultant
|
Mark Sulkowski, MD
|
Abbott, BMS, Gilead, Janssen, Merck,Roche, Vertex, Boehringer Ingelheim
|
Research Grant to John Hopkins University (PI)
|
Back to Top |
Abbott, BMS, Gilead, Janssen, Merck,Roche, Vertex, Boehringer Ingelheim
|
Scientific Advisory Panel
|
Daniel E. Everitt, MD
|
TB Alliance
|
Salary & Bonus as full time employee
|
|
PRESENTERS NOTE: The TB Alliance is a non-profit organization funded by government & private foundation (Gates) grants. It receives no revenue from product sales but works in partnerships to develop new drug regimens for treating tuberculosis.
|
Martin Markowitz, MD
|
Merck: Glead; Janssen; GSK; ViiV
|
Consultant = Honorarium
|
|
Gilead; Janssen; BMS
|
Speaker - Honorarium |
Kenneth Hugh Mayer MD
|
Gilead, Merck & BMS
|
Research Grant for PI
|
Andrew J. Muir MD MHS
|
Abbott, Achillion, BMS, Gilead, GSK, GlobeImmune, Medtronic, Merck, Pfizer, Roche, Salix, Scynexis, Vertex Pharmaceuticals
|
Grant / Research Funding
|
Back to Top |
Achillion, BMS, Merck, Profectus BioSciences Inc., Scynexis, Vertex Pharmaceuticals
|
Consulting or Other Services (including CME |
Karam Mounzer MD
|
Gilead Sciences
|
Research
|
|
Gilead Sciences
|
Speaker |
Mohamed Atta MD MPH
|
GSK, BMS
|
Advisory
|
|
GSK
|
Speaker
|
Back to Top |
Gilead |
Subcontract Grant PI |
David W. Haas MD
|
Gilead Sciences, Merck, Boehringer-Ingelheim
|
PI on research grant to Vanderbilt University
|
Richard E. Chaisson MD
|
Merck
|
Stock (wife is shareholder)
|
|
Vertex
|
Consulting fees
|
Marcus Altfeld MD PhD
|
Gilead
|
PI on research grant to Vanderbilt University
|
Calvin J. Cohen, MD MSc
|
Gilead; Bristol-Myers Squibb; Merck & Co.
|
Contracted Research
|
Back to Top |
Gilead; Bristol-Myers Squibb; Merck & Co.; Tobira
|
Honararia
|
Ian Frank, MD
|
Gilead
|
Advisor; honorarium
|
|
GlaxoSmithKline
|
Grant for Contracted research
|
Nezam H. Afdhal, MD
|
Merck, GSK, Vertex, Gilead, Abbott, BMS |
Research Support |
|
Merck, Gilead, Echosens, GSK, Vertex, Novartis, Boehringer Ingelheim, Ligan, Springbank, Medgenics, Kadmon |
Consultant / Advisory Board Member |
|
Springbank, Medgenics |
Stock Options |
Alain H. Litwin, MD MPH |
Kadmon Pharmaceutical |
Honorarium; Monograph Adherence
|
|
Janssen Pharmaceutical |
Honorarium; Advisory
Committee
|
Mark A. Wainberg, PhD |
BMS; Abbott; Merck; Gilead |
Honorarium - Speaker |
|
Janssen; Merck; Viiv
|
Unrestricted Research Grant |
Ian Frank, MD
|
Gilead
|
Advisor; honorarium
|
|
GlaxoSmithKline
|
Grant for Contracted research
|
Andrew R. Zolopa, MD
|
Gilead Sciences; Jenssen; BMS |
Advisory Board Membe |
|
Gilead Sciences |
Consultant |
|
Gilead Sciences; Pfizer; Virxsys |
Sponsored Research |
Pablo Tebas, MD
|
Glaxo
|
Honorarium for advisory committee participation |
|
Merck |
Honorarium for consulting |
|
Cytheris |
Honorarium for serving on Data and Safety Monitoring Board |
Elizabeth Lowenthal, MD MSCE FAAP AAHIVS |
BMS |
Research Contract - PI |
Gregory T. Everson, MD |
Roche/Genentech, Vertex, GlobeImmune, BMS Abbott Eisai, HGS/novartis, Pfizer, Gilead, Janssen/Tibotec |
Advisory Boards |
|
Roche-Genentech, HGS/Novartis, BMS, Three Rivers, Vertex, Abbott |
Consulting |
|
Merck, Centocor |
DSMB |
|
Source, HepQuant LLC |
Stock/Ownership |
|
HepQuant LLC |
Management |
|
Roiche/Genentech, Schering, Vertex, GlobeImmune, Gilead, HGS/Novartis, BMS, Pfizer, Source, Eisai, GSK, Pharmassett, Ortho Biotech, Janssen/Tibotec, Medtronic |
Research Grants |
Ian Frank, MD |
Gilead |
Advisor; honorarium |
|
GlaxoSmithKline |
Grant for Contracted research |
Pablo Tebas, MD |
Glaxo
|
Honorarium for advisory committee participation |
|
Merck |
Honorarium for consulting |
|
Cytheris |
Honorarium for serving on Data and Safety Monitoring Board |
Robert Gross, MD MSCE |
Pfizer |
Consulting fee; Member of DSMB for non-HIV related product |
Calvin J. Cohen, MD MSc |
Gilead; Bristol-Myers Squibb; Merck & Co.; Janssen
|
Contracted Research
|
|
Gilead; Bristol-Myers Squibb; Merck & Co.; Tobira
|
Honoraria |
Ian Frank, MD
|
Gilead
|
Advisor; honorarium
|
|
GlaxoSmithKline
|
Grant for Contracted research
|
K. Rajender Reddy, MD
|
BMS; Gilead; Vertex; Tibotec/Janssen; Merck; Genentech-Roche; Anadys; Ikaria; Hyperion
|
Contracted Research
|
|
Merck; Genentech-Roche; Gilead; Tibotec-Jannsen; Vertex
|
Consulting Fees
|
Disclosure of Unlabeled Use - years Two & Three:
Unlabeled uses no longer recorded here. See slide deck or CME handout, please.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. ViralEd, Inc., the Perelman School of Medicine at the University of Pennsylvania, Gilead Sciences and Janssen Therapeutics do not recommend the use of any agent outside of the labeled indications.
Presenter |
Product |
Investigational and/or Off-label Use |
Amy Pruitt, MD
|
Methohexate, rituxan, tenodex |
Treatment of primary CNS lymphoma |
Peter W. Hunt MD |
Dr. Hunt indicated that: |
His presentation will contain discussion of ongoing research studies of drugs targeting immune activation in treated HIV infection with the understanding that these developments cannot yet be recommended for clinical use as there is no evidence to support their use at this time. |
Luis J. Montaner, DVM DPhil |
Interferon-alpha 2a (Roche/Genentech) |
Ind for HIV mono-infected |
Roy M. Gulick, MD MPH |
|
Investigational Antiretroviral Drugs (multiple) |
Jay Kostman, MD |
Telaprevir; Boceprevir |
Co-infection |
Mark Sulkowski, MD |
|
Multiple experimental HCV agents |
Daniel E. Everitt, MD |
Clofazimine; Moxifloxacin |
Investigational use to treate TB
|
Calvin Cohen, MD MSC |
All approved HIV Antivirals
Experimental HIV Antivirals
|
All Current studies exploring off label uses
Use of these for HIV treatment
|
Kenneth Hugh Mayer MD |
Maraviroc, Dapivirine. Rilpivirine |
Chemoprophylaxis |
Amy Pruitt MD |
Mefloquine & Codofovir
Corticosteroids
|
Progressiive Multifocal Leukoencephalopathy
Immune Reconstitution Inflammatory syndrome / Progressiive Multifocal Leukoencephalopathy
|
Helen Koenig MD MPH |
Mirtazapine; Mefloquine; Cytarabine; Cidofovir 300 |
Progressiive Multifocal Leukoencephalopathy Treatment |
K. Rajendar Reddy MD |
|
I will mention several investigational drugs in clinical trials but will NOT discuss or promote off label use. The gist of the talk is to discuss recent advances in HCV therapy. |
Richard E. Chaisson MD |
Rifapentine |
Prevention of tuberculosis (currently labeled only for treatment of TB disease but recommended by the CDC for prevention |
Marcus Altfeld MD PhD |
IMO-3100 (TLR 7/9 Antagonist) |
Investigational drug developed by Idera Pharmaceuticals for psoriasis |
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of ViralEd, Inc., the Perelman School of Medicine at the University of Pennsylvania, Gilead Sciences and Janssen Therapeutics. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
Disclaimer - Years One through Three:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
You may contact Richard Gordon by phone at 1-856-506-5790 or by email at Rgordon@viraled.com for additional assistance.
We look forward to bringing the highest-quality CME directly to you.
Co-sponsors - Year One:
Co-sponsors - Years two & Three:
|